These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 12855646)
21. A quantitative promoter methylation profile of prostate cancer. Jerónimo C; Henrique R; Hoque MO; Mambo E; Ribeiro FR; Varzim G; Oliveira J; Teixeira MR; Lopes C; Sidransky D Clin Cancer Res; 2004 Dec; 10(24):8472-8. PubMed ID: 15623627 [TBL] [Abstract][Full Text] [Related]
22. Comparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate cancer. Suh CI; Shanafelt T; May DJ; Shroyer KR; Bobak JB; Crawford ED; Miller GJ; Markham N; Glode LM Mol Cell Probes; 2000 Aug; 14(4):211-7. PubMed ID: 10970725 [TBL] [Abstract][Full Text] [Related]
23. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer. Ellinger J; Haan K; Heukamp LC; Kahl P; Büttner R; Müller SC; von Ruecker A; Bastian PJ Prostate; 2008 Jan; 68(1):42-9. PubMed ID: 18004747 [TBL] [Abstract][Full Text] [Related]
24. Molecular detection of prostate cancer: a role for GSTP1 hypermethylation. Henrique R; Jerónimo C Eur Urol; 2004 Nov; 46(5):660-9; discussion 669. PubMed ID: 15474280 [TBL] [Abstract][Full Text] [Related]
25. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects. Hoque MO; Topaloglu O; Begum S; Henrique R; Rosenbaum E; Van Criekinge W; Westra WH; Sidransky D J Clin Oncol; 2005 Sep; 23(27):6569-75. PubMed ID: 16170165 [TBL] [Abstract][Full Text] [Related]
26. DNA methylation biomarkers of prostate cancer: confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detection. Payne SR; Serth J; Schostak M; Kamradt J; Strauss A; Thelen P; Model F; Day JK; Liebenberg V; Morotti A; Yamamura S; Lograsso J; Sledziewski A; Semjonow A Prostate; 2009 Sep; 69(12):1257-69. PubMed ID: 19459176 [TBL] [Abstract][Full Text] [Related]
27. Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease. Singal R; Ferdinand L; Reis IM; Schlesselman JJ Oncol Rep; 2004 Sep; 12(3):631-7. PubMed ID: 15289848 [TBL] [Abstract][Full Text] [Related]
28. Multicenter evaluation of an investigational prostate cancer methylation assay. Baden J; Green G; Painter J; Curtin K; Markiewicz J; Jones J; Astacio T; Canning S; Quijano J; Guinto W; Leibovich BC; Nelson JB; Vargo J; Wang Y; Wuxiong C J Urol; 2009 Sep; 182(3):1186-93. PubMed ID: 19625061 [TBL] [Abstract][Full Text] [Related]
29. The use of real-time quantitative polymerase chain reaction to detect hypermethylation of the CpG islands in the promoter region flanking the GSTP1 gene to diagnose prostate carcinoma. Chu DC; Chuang CK; Fu JB; Huang HS; Tseng CP; Sun CF J Urol; 2002 Apr; 167(4):1854-8. PubMed ID: 11912447 [TBL] [Abstract][Full Text] [Related]
30. Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci. Bastian PJ; Ellinger J; Wellmann A; Wernert N; Heukamp LC; Müller SC; von Ruecker A Clin Cancer Res; 2005 Jun; 11(11):4097-106. PubMed ID: 15930345 [TBL] [Abstract][Full Text] [Related]
31. Detailed methylation analysis of the glutathione S-transferase pi (GSTP1) gene in prostate cancer. Millar DS; Ow KK; Paul CL; Russell PJ; Molloy PL; Clark SJ Oncogene; 1999 Feb; 18(6):1313-24. PubMed ID: 10022813 [TBL] [Abstract][Full Text] [Related]
32. Methylation analysis of BRCA1, RASSF1, GSTP1 and EPHB2 promoters in prostate biopsies according to different degrees of malignancy. Rabiau N; Thiam MO; Satih S; Guy L; Kemeny JL; Boiteux JP; Fontana L; Bignon YJ; Bernard-Gallon D In Vivo; 2009; 23(3):387-91. PubMed ID: 19454503 [TBL] [Abstract][Full Text] [Related]
33. Promoter hypermethylation of GSTP1, AR, and 14-3-3sigma in serum of prostate cancer patients and its clinical relevance. Reibenwein J; Pils D; Horak P; Tomicek B; Goldner G; Worel N; Elandt K; Krainer M Prostate; 2007 Mar; 67(4):427-32. PubMed ID: 17192910 [TBL] [Abstract][Full Text] [Related]
34. Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy. Park S; Shinohara K; Grossfeld GD; Carroll PR J Urol; 2001 May; 165(5):1409-14. PubMed ID: 11342887 [TBL] [Abstract][Full Text] [Related]
35. CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker. Lee WH; Isaacs WB; Bova GS; Nelson WG Cancer Epidemiol Biomarkers Prev; 1997 Jun; 6(6):443-50. PubMed ID: 9184779 [TBL] [Abstract][Full Text] [Related]
37. Promoter methylation in APC, RUNX3, and GSTP1 and mortality in prostate cancer patients. Richiardi L; Fiano V; Vizzini L; De Marco L; Delsedime L; Akre O; Tos AG; Merletti F J Clin Oncol; 2009 Jul; 27(19):3161-8. PubMed ID: 19470943 [TBL] [Abstract][Full Text] [Related]
39. [Study on the diagnosis of prostatic cancer by detecting methylated GSTP1 promotor region from the urinary samples]. Kato T Hokkaido Igaku Zasshi; 2005 Mar; 80(2):251-61. PubMed ID: 15868711 [No Abstract] [Full Text] [Related]
40. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia. Kang GH; Lee S; Lee HJ; Hwang KS J Pathol; 2004 Feb; 202(2):233-40. PubMed ID: 14743506 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]